PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 64 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,940 | +80.1% | 30,000 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $4,965 | -83.0% | 30,000 | 0.0% | 0.00% | -80.0% |
Q1 2023 | $29,280 | -6.2% | 30,000 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $31,200 | -10.9% | 30,000 | 0.0% | 0.01% | -16.7% |
Q3 2022 | $35,000 | -37.5% | 30,000 | 0.0% | 0.01% | -33.3% |
Q2 2022 | $56,000 | -38.5% | 30,000 | 0.0% | 0.01% | -25.0% |
Q1 2022 | $91,000 | -19.5% | 30,000 | 0.0% | 0.01% | -14.3% |
Q4 2021 | $113,000 | -27.1% | 30,000 | 0.0% | 0.01% | -33.3% |
Q3 2021 | $155,000 | +34.8% | 30,000 | 0.0% | 0.02% | +40.0% |
Q2 2021 | $115,000 | +49.4% | 30,000 | 0.0% | 0.02% | +36.4% |
Q1 2021 | $77,000 | +2.7% | 30,000 | 0.0% | 0.01% | -8.3% |
Q4 2020 | $75,000 | +21.0% | 30,000 | 0.0% | 0.01% | +9.1% |
Q3 2020 | $62,000 | -33.3% | 30,000 | 0.0% | 0.01% | -35.3% |
Q2 2020 | $93,000 | +36.8% | 30,000 | 0.0% | 0.02% | +6.2% |
Q1 2020 | $68,000 | -37.6% | 30,000 | 0.0% | 0.02% | -15.8% |
Q4 2019 | $109,000 | +6.9% | 30,000 | 0.0% | 0.02% | 0.0% |
Q3 2019 | $102,000 | – | 30,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 778,230 | $5,308,000 | 5.22% |
BVF INC/IL | 3,592,549 | $24,501,000 | 2.48% |
Prosight Management, LP | 563,763 | $3,845,000 | 2.41% |
SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $5,456,000 | 0.83% |
Virtus ETF Advisers LLC | 125,695 | $857,000 | 0.74% |
EAM Investors, LLC | 521,460 | $3,556,000 | 0.59% |
Tekla Capital Management LLC | 2,087,380 | $14,236,000 | 0.55% |
Orbimed Advisors | 5,550,000 | $37,851,000 | 0.47% |
EAM Global Investors LLC | 125,635 | $857,000 | 0.44% |
Schonfeld Strategic Advisors LLC | 830,637 | $5,665,000 | 0.42% |